Oncology Institute Stock Forecast - Daily Balance Of Power

TOI Stock  USD 0.17  0.02  13.33%   
Oncology Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Oncology Institute's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
As of now, Oncology Institute's Inventory Turnover is decreasing as compared to previous years. The Oncology Institute's current Receivables Turnover is estimated to increase to 9.85, while Payables Turnover is projected to decrease to 12.19. . The Oncology Institute's current Net Income Applicable To Common Shares is estimated to increase to about 64.3 K, while Common Stock Shares Outstanding is projected to decrease to under 68.4 M.
On October 1, 2024 Oncology Institute had Daily Balance Of Power of (0.50). Balance of Power indicator (or BOP) measures the strength of Oncology Institute market sensitivity to bulls and bears. It estimates the ability of Oncology Institute buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Oncology Institute Balance of Power indicator one can determine a trend of the price direction.
Check Oncology Institute VolatilityBacktest Oncology InstituteTrend Details  

Oncology Institute Trading Date Momentum

On October 02 2024 Oncology Institute was traded for  0.32  at the closing time. Highest Oncology Institute's price during the trading hours was 0.33  and the lowest price during the day was  0.31 . The net volume was 39.6 K. The overall trading history on the 2nd of October did not cause price change. The trading delta at closing time to current price is 3.13% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Oncology Institute to competition

Other Forecasting Options for Oncology Institute

For every potential investor in Oncology, whether a beginner or expert, Oncology Institute's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncology Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncology. Basic forecasting techniques help filter out the noise by identifying Oncology Institute's price trends.

View Oncology Institute Related Equities

 Risk & Return  Correlation

Oncology Institute Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncology Institute's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncology Institute's current price.

Oncology Institute Market Strength Events

Market strength indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By undertsting and applying Oncology Institute stock market strength indicators, traders can identify Oncology Institute entry and exit signals to maximize returns.

Oncology Institute Risk Indicators

The analysis of Oncology Institute's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncology Institute's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncology stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.77)
Revenue Per Share
4.873
Quarterly Revenue Growth
0.229
Return On Assets
(0.19)
Return On Equity
(1.26)
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.